Preview

Bulletin of Siberian Medicine

Advanced search

The prevalence of the sleep disturbances among the patients with substance use disorders

https://doi.org/10.20538/1682-0363-2019-4-26-35

Abstract

Background. There is evidence that sleep disorders may be significantly linked to the development of the substance use disorders (SUD). However, data about the prevalence of the sleep disturbances among patients with SUD in Russia are relatively limited.

Aim. To evaluate the frequency of the sleep disturbances among patients (n = 196) with alcohol (ÀD, n = 102), opioid (ÎD, n = 55) and polysubstance dependence (PD, n = 39) seeking addiction medical care.

Materials and methods. We conduct a cross-sectional study of sleep disturbances among patients in St. Petersburg in 2017–2018. The modified Insomnia Severity Index (ISI) was administered to assess sleep during different periods of time: lifetime, the past 12 months, and the past 30 days.

Results. All groups demonstrated relatively high presence of different sleep disorders (range: 49.0–76.5% among 196). The sleep disturbances over the past 30 days were more common in the AD group (60.8– 73.5% among 102) with the early morning awakening as the most frequent complaint. In the PD group the prevalence of lifetime sleep disturbances was high (94.9–100.0% among 39), whereas insomnia disorders were relatively rare over the past 30 days. However, it was sleep disturbances over the past 30 days that were statistically significantly more often (p < 0,05) observed in the group of patients who actively consume narcotic substances (40.2–87.2%), compared with the group of patients in remission (0–16.7%).

Conclusion. The results demonstrated the high prevalence of insomnia among patients with SUD and suggested that the remission have a positive effect on the symptoms of sleep disorders. Further studies of the association between sleep disturbances and SUD progression are needed. 

About the Authors

M. V. Vetrova
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology; I.P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Research Associate, Laboratory of Clinical Pharmacology of Addictions,

3, Bekhterev Str., Saint Petersburg, 192019;

6/8, L’va Tolstogo Str., Saint Petersburg, 197089



D. N. Kuchmenko
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

Junior Researcher, Department of Addictions,

3, Bekhterev Str., Saint Petersburg, 192019



I. N. Genina
State Addiction Hospital
Russian Federation

Addiction Psychiatrist, Head of the Department,

48, 5th line of Vasilyevsky Island, Saint Petersburg, 199004



O. V. Goncharov
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

PhD, Senior Researcher, Department of Addictions,

3, Bekhterev Str., Saint Petersburg, 192019



K. V. Rybakova
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

V., PhD, Leading Researcher, Department of Addictions, 

3, Bekhterev Str., Saint Petersburg, 192019



N. V. Semenova
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

DM, Senior Researcher, Chief of the Research Organization Department,

3, Bekhterev Str., Saint Petersburg, 192019



E. Yu. Zubova
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

DM, Chief of the Training Center,

3, Bekhterev Str., Saint Petersburg, 192019



A. S. Kiselev
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

Biostatistician,

3, Bekhterev Str., Saint Petersburg, 192019



N. G. Neznanov
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology
Russian Federation

DM, Professor, Director,

3, Bekhterev Str., Saint Petersburg, 192019



E. M. Krupitsky
V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology; I.P. Pavlov First Saint Petersburg State Medical University
Russian Federation

DM, Professor, Deputy Director for Science and Head of the Department of Addictions, 3, Bekhterev Str., Saint Petersburg, 192019;

Chief of the Laboratory of Clinical Psychopharmacology of Addictions, 6/8, L’va Tolstogo Str., Saint Petersburg, 197089



References

1. Smith N., Hill R., Marshall J., Keaney F., Wanigaratne S. Sleep related beliefs and their association with alcohol relapse following residential alcohol detoxification treatment. Behav. Cogn. Psychother. 2014; 42 (5): 593–604. DOI: 10.1017/S1352465813000465.

2. Angarita G.A., Emadi N., Hodges S., Morgan P.T. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict. Sci. Clin. Pract. 2016; 11 (1): 9. DOI: 10.1186/ s13722-016-0056-7.

3. Roehrs T.A., Roth T. Sleep disturbance in substance use disorders. Psychiatr. Clin. North Am. 2015; 38 (4): 793–803. DOI: 10.1016/j.psc.2015.07.008.

4. Sorscher A.J., Siddiqui A.A., Olson A., Johnson D. Pharmacotherapy for сhronic insomnia: A brief survey of PCP attitudes and preferences. J. Sleep Disor: Treat Care. 2016; 5: 1. DOI: 10.4172/2325-9639.1000169.

5. Poluehktov M.G., Levin Yа.I. Sleep disorders and their treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2010; 110 (9): 70–75. (in Russ.).

6. Brower K.J. Insomnia, alcoholism and relapse. Sleep Med. Rev. 2003; 7 (6): 523–539. DOI: 10.1016/S1087-0792(03)90005-0.

7. Miller M.B., Donahue M.L., Carey K.B., Scott-Sheldon L.A. Insomnia treatment in the context of alcohol use disorder: a systematic review and meta-analysis. Drug. Alcohol. Depend. 2017; 181: 200–207. DOI: 10.1016/j.drugalcdep.2017.09.029.

8. Morin C.M., Belleville G., Bйlanger L., Ivers H. The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response. Sleep. 2011; 34 (5): 601–608. DOI: 10.1093/sleep/34.5.601.

9. Cohn T., Foster J., Peters T. Sequential studies of sleep disturbance and quality of life in abstaining alcoholics. Addict. Biol. 2003; 8 (4): 455–462. DOI: 10.1080/13556210310001646439.

10. Golenkov A.V., Poluektov M.G. The prevalence of sleep disorders among residents of Chuvashia (data from a continuous questionnaire survey). S.S. Korsakov Journal of Neurology and Psychiatry. 2011; 111 (6): 64–67 (in Russ.).

11. Brower K.J., Krentzman A., Robinson E.A.R. Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals. Am. J. Addict. 2011; 20 (5): 435–440. DOI: 10.1111/j.1521-0391.2011.00152.x.

12. Brower K.J. Assessing and treating insomnia related to alcohol use disorders. Curr. Addict. Rep. 2016; 3 (1): 98–108. DOI: 10.1007/s40429-016-0083-1.

13. Brower K.J., Perron B.E. Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Med. Hypotheses. Elsevier Ltd. 2010; 74 (5): 928–933. DOI: 10.1016/j.mehy.2009.10.020.

14. Dolsen M.R., Harvey A.G. Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994. Addiction. 2017; 112 (6): 1104–1111. DOI: 10.1111/add.13772.


Review

For citations:


Vetrova M.V., Kuchmenko D.N., Genina I.N., Goncharov O.V., Rybakova K.V., Semenova N.V., Zubova E.Yu., Kiselev A.S., Neznanov N.G., Krupitsky E.M. The prevalence of the sleep disturbances among the patients with substance use disorders. Bulletin of Siberian Medicine. 2019;18(4):26-35. (In Russ.) https://doi.org/10.20538/1682-0363-2019-4-26-35

Views: 1301


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-0363 (Print)
ISSN 1819-3684 (Online)